Scandion Oncology A/S Cash Flow Reinvestment Rate
Latest as of September 2020:
0.20x
Scandion Oncology A/S cash flow reinvestment rate. Scandion Oncology A/S (SCOL) has a Cash Flow Reinvestment Rate of 0.20x as of September 2020, reinvesting Skr46.00K (capex Skr0.00 plus investments Skr-46.00K) from operating cash flow of Skr229.00K. Explore SCOL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.20x
(Capex + Investments) / Operating CF
Total Reinvested
Skr46.00K
Capex + Investments
Operating Cash Flow
Skr229.00K
SEK
Capital Expenditures
Skr0.00
SEK
Scandion Oncology A/S Cash Flow Reinvestment Rate by Year (None–None)
Scandion Oncology A/S cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Scandion Oncology A/S. For the full cash flow conversion analysis, see Scandion Oncology A/S cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow